Dec. 14, 2023, 4:44 PM CST
Rising rates of flu, Covid and RSV prompted the agency to urge clinicians to push for more vaccinations.
Not enough Americans are being vaccinated against Covid, the flu and RSV to stem rising numbers of the respiratory illnesses, the Centers for Disease Control and Prevention said Thursday.
The agency issued a health alert to doctors across the country, warning that low vaccination rates amid “ongoing increases in national and international respiratory disease activity” could strain U.S. health care systems in the coming weeks, and called on doctors to encourage their patients to get the shots immediately to protect them for the remainder of the season.
“In the past 4 weeks, hospitalizations among all age groups increased by 200% for influenza, 51% for Covid-19, and 60% for RSV,” the CDC said in its health alert. “Currently, the highest respiratory disease activity in the United States is occurring across the southern half of the country, with increasing activity in northern states.”
As of Dec. 8, just 17.2% of adults had received the updated Covid shot, according to the CDC. About 40% of children and adults have gotten this year’s flu shot. And 15.9% of older adults eligible for the RSV vaccine have received it.
Rising illnesses in children
The warning comes as illnesses are increasing among children — including an apparent uptick in a rare Covid-related complication called MIS-C, the CDC said. Cases had appeared to drop in recent years.
But from September to mid-December, the CDC received 30 such reports in kids, reflecting a “relative increase” compared with previous months.
Doctors should not hoard the few doses they have of the drug, called Beyfortus, the CDC said, and instead give all they can now, rather than wait for the situation to possibly worsen later this season. The CDC recommends Beyfortus for babies and toddlers up to 19 months old.
On Thursday, the Biden administration announced that it had worked with drug companies to release an additional 230,000 doses of the drug, expected in January.